Jeffrey Ubben
ValueAct Holdings
Jeffrey Ubben Liberty Live Holdings, Inc Series A Liberty Live Group stake
total: 107
ValueAct Holdings LLYVA trades
- Total transactions:
- 8
- New positions:
- 1
- Added:
- 4
- Reduced:
- 3
- Held since:
- 2024 Q3
- Held for:
- 8 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Jeffrey Ubben holds 785,119 Liberty Live Holdings, Inc Series A Liberty Live Group (LLYVA) shares with a market value of roughly $79.50M accounting for 1.41% of the overall portfolio. To date, the estimated cost basis is nearly $61.96 for "buy" trades and estimated average "sell" price is $100.71. ValueAct Holdings first purchased LLYVA in 2024 Q3, initially acquiring 671,800 shares. Since the initial investment in Liberty Live Holdings, Inc Series A Liberty Live Group (LLYVA), ValueAct Holdings has made 7 more transactions.
When did Jeffrey Ubben buy Liberty Live Holdings, Inc Series A Liberty Live Group (LLYVA)?
Jeffrey Ubben first invested in Liberty Live Holdings, Inc Series A Liberty Live Group (LLYVA) in 2024 Q3 at the reported quarter-end price of $49.51 per share.
What's the cost basis of ValueAct Holdings's LLYVA stake?
The estimated cost basis for Liberty Live Holdings, Inc Series A Liberty Live Group (LLYVA) stake is around $61.96 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $61.96
- Weighted AVG sell price:
- $100.71
Jeffrey Ubben's historical trades in Liberty Live Holdings, Inc Series A Liberty Live Group
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.41%
|
785,119
|
$101.26
|
$79,501,150
|
-55.82% (-991,956)
|
-1.76%
|
|
2026 Q1
|
2.85%
|
1,777,075
|
$91.64
|
$162,851,153
|
-1.24% (-22,244)
|
-0.03%
|
|
2025 Q4
|
2.09%
|
1,799,319
|
$81.50
|
$146,644,499
|
+4.64% (+79,771)
|
+0.09%
|
|
2025 Q3
|
2.73%
|
1,719,548
|
$94.30
|
$162,153,376
|
-3.02% (-53,600)
|
-0.09%
|
|
2025 Q2
|
2.52%
|
1,773,148
|
$79.48
|
$140,929,803
|
+6.90% (+114,500)
|
+0.16%
|
|
2025 Q1
|
2.43%
|
1,658,648
|
$67.24
|
$111,527,492
|
+30.76% (+390,200)
|
+0.57%
|
|
2024 Q4
|
1.92%
|
1,268,448
|
$66.56
|
$84,427,899
|
+88.81% (+596,648)
|
+0.9%
|
|
2024 Q3
|
0.76%
|
671,800
|
$49.51
|
$33,260,818
|
new
|
+0.76%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.